This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (10)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cardiovascular System, Other  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Arch Intern Med. 2003;163:877-878.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

PERIPHERAL arterial disease (PAD) is common and associated with considerable morbidity and mortality. Caused by atherosclerotic occlusion of the leg arteries, PAD is a manifestation of systemic atherosclerosis with a prevalence of approximately 12%, affecting men and women equally.¹ Even in the absence of a history of myocardial infarction or stroke, the relative risk of death from cardiovascular causes in patients with PAD is about the same as in patients with coronary or cerebrovascular disease. The risk of death is increased whether or not PAD is symptomatic, and patients with critical leg ischemia (the most severe form of PAD) face an annual mortality of 25%, which is overwhelmingly due to myocardial infarction and ischemic stroke.² As a marker of systemic atherosclerosis, PAD demands a comprehensive clinical approach that fosters prevention, detection, and timely intervention. In this issue of the ARCHIVES, the Executive Committee of the Prevention of Atherothrombotic Disease Network³ . . . [Full Text of this Article]

RELATED ARTICLE

Critical Issues in Peripheral Arterial Disease Detection and Management: A Call to Action
Jill J. F. Belch, Eric J. Topol, Giancarlo Agnelli, Michel Bertrand, Robert M. Califf, Denis L. Clement, Mark A. Creager, J. Donald Easton, James R. Gavin, III, Philip Greenland, Graeme Hankey, Peter Hanrath, Alan T. Hirsch, Jürgen Meyer, Sidney C. Smith, Frank Sullivan, and Michael A. Weber
Arch Intern Med. 2003;163(8):884-892.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetic Susceptibility to Peripheral Arterial Disease: A Dark Corner in Vascular Biology
Knowles et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:2068-2078.
ABSTRACT | FULL TEXT  

The effect of current cigarette smoking on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication
Afaq et al.
Vasc Med 2007;12:167-173.
ABSTRACT  

Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999-2000
Selvin and Erlinger
Circulation 2004;110:738-743.
ABSTRACT | FULL TEXT  

Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease
Carr et al.
Am. J. Physiol. Heart Circ. Physiol. 2004;287:H268-H276.
ABSTRACT | FULL TEXT